Věra Stejskal

1.8k total citations
49 papers, 1.4k citations indexed

About

Věra Stejskal is a scholar working on Dermatology, Psychiatry and Mental health and Immunology. According to data from OpenAlex, Věra Stejskal has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Dermatology, 15 papers in Psychiatry and Mental health and 13 papers in Immunology. Recurrent topics in Věra Stejskal's work include Contact Dermatitis and Allergies (15 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (14 papers) and Heavy Metal Exposure and Toxicity (8 papers). Věra Stejskal is often cited by papers focused on Contact Dermatitis and Allergies (15 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (14 papers) and Heavy Metal Exposure and Toxicity (8 papers). Věra Stejskal collaborates with scholars based in Sweden, Czechia and Norway. Věra Stejskal's co-authors include Margit Forsbeck, Peter Perlmann, Geir Bjørklund, I Šterzl, Karin Cederbrant, Anders Lindvall, Jiřina Bártová, C O'Toole, Malin Karlsson and J Procházková and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Věra Stejskal

47 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Věra Stejskal Sweden 20 361 287 246 176 175 49 1.4k
Hans‐Christian Schuppe Germany 25 206 0.6× 232 0.8× 472 1.9× 76 0.4× 46 0.3× 78 2.2k
J Procházková Czechia 13 106 0.3× 75 0.3× 127 0.5× 42 0.2× 55 0.3× 48 961
P Thune Norway 26 71 0.2× 905 3.2× 341 1.4× 112 0.6× 32 0.2× 98 1.9k
Cevdet Özdemir Türkiye 23 112 0.3× 457 1.6× 348 1.4× 35 0.2× 92 0.5× 76 1.9k
Tomasz Paszkowski Poland 24 181 0.5× 118 0.4× 341 1.4× 133 0.8× 27 0.2× 122 2.0k
Zeynep Çelebi Sözener Türkiye 12 143 0.4× 206 0.7× 290 1.2× 74 0.4× 27 0.2× 33 1.3k
Chang‐Hung Kuo Taiwan 21 160 0.4× 97 0.3× 264 1.1× 48 0.3× 26 0.1× 50 1.2k
Mark D. Farrar United Kingdom 21 149 0.4× 587 2.0× 94 0.4× 167 0.9× 20 0.1× 48 1.5k
J. Preiß Germany 21 138 0.4× 69 0.2× 402 1.6× 68 0.4× 29 0.2× 80 1.7k
I Šterzl Czechia 19 96 0.3× 80 0.3× 158 0.6× 67 0.4× 66 0.4× 72 906

Countries citing papers authored by Věra Stejskal

Since Specialization
Citations

This map shows the geographic impact of Věra Stejskal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Věra Stejskal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Věra Stejskal more than expected).

Fields of papers citing papers by Věra Stejskal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Věra Stejskal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Věra Stejskal. The network helps show where Věra Stejskal may publish in the future.

Co-authorship network of co-authors of Věra Stejskal

This figure shows the co-authorship network connecting the top 25 collaborators of Věra Stejskal. A scholar is included among the top collaborators of Věra Stejskal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Věra Stejskal. Věra Stejskal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klener, Pavel, et al.. (2020). The benefits of ascorbate to protect healthy cells in the prevention and treatment of oncological diseases. Journal of Applied Biomedicine. 18(1). 1–7. 2 indexed citations
2.
Bjørklund, Geir, Věra Stejskal, Mauricio A. Urbina, et al.. (2018). Metals and Parkinson's Disease: Mechanisms and Biochemical Processes. Current Medicinal Chemistry. 25(19). 2198–2214. 139 indexed citations
3.
Andršová, Irena, Věra Stejskal, Milan Sepši, et al.. (2017). Hypersensitivity to material and environmental burden as a possible cause of late complications of cardiac implantable electronic devices. EP Europace. 20(9). e140–e147. 10 indexed citations
4.
Stejskal, Věra, Jiří Jarkovský, Petr Němec, et al.. (2016). Delayed-Type Hypersensitivity to Metals of Environmental Burden in Patients with Takotsubo Syndrome – Is There a Clinical Relevance?. PLoS ONE. 11(11). e0164786–e0164786. 6 indexed citations
5.
Fireman, Elizabeth, et al.. (2016). Identification of metal sensitization in sarcoid-like metal-exposed patients by the MELISA® lymphocyte proliferation test — a pilot study. Journal of Occupational Medicine and Toxicology. 11(1). 18–18. 25 indexed citations
6.
Stejskal, Věra, Tim Reynolds, & Geir Bjørklund. (2015). Increased frequency of delayed type hypersensitivity to metals in patients with connective tissue disease. Journal of Trace Elements in Medicine and Biology. 31. 230–236. 42 indexed citations
7.
Stejskal, Věra. (2013). Mercury-induced inflammation: yet another example of ASIA syndrome.. PubMed. 15(11). 714–5. 13 indexed citations
8.
Benada, Oldřích, Jiřina Bártová, Luděk Joska, et al.. (2006). In vivo effects of dental casting alloys.. PubMed. 27 Suppl 1. 61–4. 17 indexed citations
9.
Stejskal, Věra, et al.. (2006). Diagnosis and treatment of metal-induced side-effects.. PubMed. 27 Suppl 1. 7–16. 51 indexed citations
10.
Procházková, J, I Šterzl, Hana Kučerová, Jiřina Bártová, & Věra Stejskal. (2004). The beneficial effect of amalgam replacement on health in patients with autoimmunity.. PubMed. 25(3). 211–8. 52 indexed citations
11.
Procházková, J, et al.. (2000). HLA‐Association in Patients with Intolerance to Mercury and Other Metals in Dental Materials. Disease Markers. 16(3-4). 135–138. 9 indexed citations
12.
Šterzl, I, et al.. (1999). Mercury and nickel allergy: risk factors in fatigue and autoimmunity.. PubMed. 20(3-4). 221–228. 54 indexed citations
13.
Stejskal, Věra, et al.. (1996). Mercury-specific lymphocytes: An indication of mercury allergy in man. Journal of Clinical Immunology. 16(1). 31–40. 58 indexed citations
14.
Stejskal, Věra, et al.. (1994). MELISA 金属アレルギーの研究のためのin vitroでの手段. Toxicology in Vitro. 8(5). 991–1000. 1 indexed citations
15.
Stejskal, Věra, Karin Cederbrant, Anders Lindvall, & Margit Forsbeck. (1994). MELISA—an in vitro tool for the study of metal allergy. Toxicology in Vitro. 8(5). 991–1000. 78 indexed citations
16.
Sundwall, A., Bo Andersson, Michael Balls, et al.. (1994). Workshop: Immunotoxicology and in vitro possibilities. Toxicology in Vitro. 8(5). 1067–1074. 4 indexed citations
17.
Stejskal, Věra, Robert Nilsson, & Arne Grepe. (1990). Immunologic basis for adverse reactions to radiographic contrast media.. PubMed. 31(6). 605–12. 12 indexed citations
18.
Stejskal, Věra, Robert Nilsson, & Arne Grepe. (1990). Immunologic Basis for Adverse Reactions to Radiographic Contrast Media. Acta Radiologica. 31(6). 605–612. 6 indexed citations
19.
Stejskal, Věra, Margit Forsbeck, & Robert Nilsson. (1990). Lymphocyte Transformation Test for Diagnosis of Isothiazolinone Allergy in Man. Journal of Investigative Dermatology. 94(6). 798–802. 37 indexed citations
20.
Holm, G., Věra Stejskal, & Peter Perlmann. (1973). Cytotoxic effects of activated lymphocytes and their supernatants.. PubMed. 14(2). 169–79. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026